NCT07188116Not yet recruiting
Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer
Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer: A Historical Cohort Study
Source: ClinicalTrials.gov · Last updated 23 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study was designed as a single-center retrospective analysis aimed at investigating whether COVID-19 infection increases the risk or burden of radiation-induced pneumonitis in breast cancer patients.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 22 Sept 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Zhejiang Hospital
- NCT number
- NCT07188116
What you commit to
- Study type: Observational
- Planned participants: 200
- From 15 Sept 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- concomitant pulmonary malignancies,
- a history of prior thoracic radiotherapy,
- concurrent pulmonary infections other than COVID-19 during radiotherapy,
Other illness
- or any other condition considered unsuitable for enrollment by the investigators.
Other
- missing key data with loss to follow-up,
Who the study is looking for
- patients with pathologically or cytologically confirmed primary breast cancer,
- aged 18 years or older but younger than 80 years,
- with complete and reliable medical records,
- for those with COVID-19 infection, documented evidence of a positive test result.
Age in the registry: 18 years to 80 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zhejiang Hospital, Department of Oncology, Hangzhou, China, 310030 Coordinator of this site? Confirm its status | Hangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.